Your institution may have access to this item. Find your institution then sign in to continue.

Title: Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.
Authors: Larsen, Jeremy T.; Shanafelt, Tait D.; Leis, Jose F.; LaPlant, Betsy; Call, Tim; Pettinger, Adam; Hanson, Curtis; Erlichman, Charles; Habermann, Thomas Matthew; Reeder, Craig; Nikcevich, Daniel; Bowen, Deborah; Conte, Michael; Boysen, Justin; Secreto, Charla; Lesnick, Connie; Tschumper, Renee; Jelinek, Diane; Kay, Neil E.; Ding, Wei
Publication: American Journal of Hematology, 2017, Vol 92, Issue 8, p759
ISSN: 0361-8609
Publication type: Academic Journal
DOI: 10.1002/ajh.24762

We found a match

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.